Afatinib plus EGF pathway targeting immunization (EGF-PTI) as first line therapy for EGFR mutant NSCLC: The EPICAL study

Simple item page
dc.contributor.authorKarachaliou, N.
dc.contributor.authorCardona Zorrilla, A.
dc.contributor.authorRodriguez-Abreu, D.
dc.contributor.authorCobo Dols, M.
dc.contributor.authorReguart Aransay, N.
dc.contributor.authorViteri, S.
dc.contributor.authorCodony-Servat, J.
dc.contributor.authorMolina-Vila, M. A.
dc.contributor.authorD'Hondt, E.
dc.contributor.authorRosell, R.
dc.contributor.authoraffiliation[Karachaliou, N.] Hosp Sagrado Corazon, Inst Oncol Dr Rosell IOR, Barcelona, Spain
dc.contributor.authoraffiliation[Cardona Zorrilla, A.] Clin Country, Clin & Translat Oncol Grp, Bogota, Colombia
dc.contributor.authoraffiliation[Rodriguez-Abreu, D.] Hosp Univ Insular Gran Canaria, Med Oncol, Las Palmas Gran Canaria, Spain
dc.contributor.authoraffiliation[Cobo Dols, M.] Hosp Reg Univ Carlos Haya, Med Oncol, Malaga, Spain
dc.contributor.authoraffiliation[Reguart Aransay, N.] Hosp Clin Barcelona, Barcelona, Spain
dc.contributor.authoraffiliation[Viteri, S.] Hosp Univ Quiron Dexeus, Inst Oncol Dr Rosell IOR, Barcelona, Spain
dc.contributor.authoraffiliation[Codony-Servat, J.] Quiron Dexeus Univ Inst, Lab Cellular & Mol Biol, Pangaea Oncol, IOR, Barcelona, Spain
dc.contributor.authoraffiliation[Molina-Vila, M. A.] Quiron Dexeus Univ Inst, Lab Cellular & Mol Biol, Pangaea Oncol, IOR, Barcelona, Spain
dc.contributor.authoraffiliation[D'Hondt, E.] Bioven, Kruibeke, Belgium
dc.contributor.authoraffiliation[Rosell, R.] Hosp Badalona Germans Trias & Pujol, Canc Biol & Precis Med Program, Germans Trias & Pujol Sci Inst, Catalan Inst Oncol ICO Badalona, Barcelona, Spain
dc.contributor.funderBioven
dc.date.accessioned2025-01-07T12:15:29Z
dc.date.available2025-01-07T12:15:29Z
dc.date.issued2018-04-01
dc.identifier.doi10.1016/S1556-0864(18)30471-4
dc.identifier.essn1556-1380
dc.identifier.issn1556-0864
dc.identifier.unpaywallURLhttp://www.jto.org/article/S1556086418304714/pdf
dc.identifier.urihttps://hdl.handle.net/10668/24379
dc.identifier.wosID436557600192
dc.issue.number4
dc.issue.numberS
dc.journal.titleJournal of thoracic oncology
dc.journal.titleabbreviationJ. thorac. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Regional de Málaga
dc.page.numberS118-S119
dc.publisherElsevier science inc
dc.rights.accessRightsopen access
dc.titleAfatinib plus EGF pathway targeting immunization (EGF-PTI) as first line therapy for EGFR mutant NSCLC: The EPICAL study
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number13
dc.wostypeMeeting Abstract

Files

Collections

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS)

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía